-
Nursing to regulator, rowing to digital health
Elin Haf Davies
Interview: Clinical Investigation
-
Nursing to regulator, rowing to digital health
Elin Haf Davies
Interview: Clinical Investigation
-
Nursing to regulator, rowing to digital health
Elin Haf Davies
Interview: Clinical Investigation
-
Nursing to regulator, rowing to digital health
Elin Haf Davies
Interview: Clinical Investigation
-
Nursing to regulator, rowing to digital health
Elin Haf Davies
Interview: Clinical Investigation
-
Nursing to regulator, rowing to digital health
Elin Haf Davies
Interview: Clinical Investigation
-
Nursing to regulator, rowing to digital health
Elin Haf Davies
Interview: Clinical Investigation
-
Nursing to regulator, rowing to digital health
Elin Haf Davies
Interview: Clinical Investigation
-
Clinical progress for enterovirus 71 vaccines: what does the future hold?
Jing-Xin Li, Feng-Cai Zhu
Editorial: Clinical Investigation
-
Clinical progress for enterovirus 71 vaccines: what does the future hold?
Jing-Xin Li, Feng-Cai Zhu
Editorial: Clinical Investigation
-
Clinical progress for enterovirus 71 vaccines: what does the future hold?
Jing-Xin Li, Feng-Cai Zhu
Editorial: Clinical Investigation
-
Clinical progress for enterovirus 71 vaccines: what does the future hold?
Jing-Xin Li, Feng-Cai Zhu
Editorial: Clinical Investigation
-
Clinical progress for enterovirus 71 vaccines: what does the future hold?
Jing-Xin Li, Feng-Cai Zhu
Editorial: Clinical Investigation
-
Clinical progress for enterovirus 71 vaccines: what does the future hold?
Jing-Xin Li, Feng-Cai Zhu
Editorial: Clinical Investigation
-
Clinical progress for enterovirus 71 vaccines: what does the future hold?
Jing-Xin Li, Feng-Cai Zhu
Editorial: Clinical Investigation
-
Clinical progress for enterovirus 71 vaccines: what does the future hold?
Jing-Xin Li, Feng-Cai Zhu
Editorial: Clinical Investigation
-
Low-dose enteric-coated aspirin does not inhibit thromboxane B2 and prostaglandin E2: data-derived hypothesis formulation***Low-dose enteric-coated aspirin and platelets
Charles H Hennekens, Scott Hetzel, Michael Pfeffer, Ricky Schneider, Steven Borzak, Wendy Schneider, Victor Serebruany,David DeMets
Research Article: Clinical Investigation
-
Low-dose enteric-coated aspirin does not inhibit thromboxane B2 and prostaglandin E2: data-derived hypothesis formulation***Low-dose enteric-coated aspirin and platelets
Charles H Hennekens, Scott Hetzel, Michael Pfeffer, Ricky Schneider, Steven Borzak, Wendy Schneider, Victor Serebruany,David DeMets
Research Article: Clinical Investigation
-
Low-dose enteric-coated aspirin does not inhibit thromboxane B2 and prostaglandin E2: data-derived hypothesis formulation***Low-dose enteric-coated aspirin and platelets
Charles H Hennekens, Scott Hetzel, Michael Pfeffer, Ricky Schneider, Steven Borzak, Wendy Schneider, Victor Serebruany,David DeMets
Research Article: Clinical Investigation
-
Low-dose enteric-coated aspirin does not inhibit thromboxane B2 and prostaglandin E2: data-derived hypothesis formulation***Low-dose enteric-coated aspirin and platelets
Charles H Hennekens, Scott Hetzel, Michael Pfeffer, Ricky Schneider, Steven Borzak, Wendy Schneider, Victor Serebruany,David DeMets
Research Article: Clinical Investigation
-
Low-dose enteric-coated aspirin does not inhibit thromboxane B2 and prostaglandin E2: data-derived hypothesis formulation***Low-dose enteric-coated aspirin and platelets
Charles H Hennekens, Scott Hetzel, Michael Pfeffer, Ricky Schneider, Steven Borzak, Wendy Schneider, Victor Serebruany,David DeMets
Research Article: Clinical Investigation
-
Low-dose enteric-coated aspirin does not inhibit thromboxane B2 and prostaglandin E2: data-derived hypothesis formulation***Low-dose enteric-coated aspirin and platelets
Charles H Hennekens, Scott Hetzel, Michael Pfeffer, Ricky Schneider, Steven Borzak, Wendy Schneider, Victor Serebruany,David DeMets
Research Article: Clinical Investigation
-
Low-dose enteric-coated aspirin does not inhibit thromboxane B2 and prostaglandin E2: data-derived hypothesis formulation***Low-dose enteric-coated aspirin and platelets
Charles H Hennekens, Scott Hetzel, Michael Pfeffer, Ricky Schneider, Steven Borzak, Wendy Schneider, Victor Serebruany,David DeMets
Research Article: Clinical Investigation
-
Low-dose enteric-coated aspirin does not inhibit thromboxane B2 and prostaglandin E2: data-derived hypothesis formulation***Low-dose enteric-coated aspirin and platelets
Charles H Hennekens, Scott Hetzel, Michael Pfeffer, Ricky Schneider, Steven Borzak, Wendy Schneider, Victor Serebruany,David DeMets
Research Article: Clinical Investigation
-
Personalized medicine in hepatocellular carcinoma: rationale and clinical data
Maria Pipa-Muniz1, Maria Varela, Luisa Gonzalez-Dieguez,Manuel Rodguez
Therapeutic Prospective: Clinical Investigation
-
Personalized medicine in hepatocellular carcinoma: rationale and clinical data
Maria Pipa-Muniz1, Maria Varela, Luisa Gonzalez-Dieguez,Manuel Rodguez
Therapeutic Prospective: Clinical Investigation
-
Personalized medicine in hepatocellular carcinoma: rationale and clinical data
Maria Pipa-Muniz1, Maria Varela, Luisa Gonzalez-Dieguez,Manuel Rodguez
Therapeutic Prospective: Clinical Investigation
-
Personalized medicine in hepatocellular carcinoma: rationale and clinical data
Maria Pipa-Muniz1, Maria Varela, Luisa Gonzalez-Dieguez,Manuel Rodguez
Therapeutic Prospective: Clinical Investigation
-
Personalized medicine in hepatocellular carcinoma: rationale and clinical data
Maria Pipa-Muniz1, Maria Varela, Luisa Gonzalez-Dieguez,Manuel Rodguez
Therapeutic Prospective: Clinical Investigation
-
Personalized medicine in hepatocellular carcinoma: rationale and clinical data
Maria Pipa-Muniz1, Maria Varela, Luisa Gonzalez-Dieguez,Manuel Rodguez
Therapeutic Prospective: Clinical Investigation
-
Personalized medicine in hepatocellular carcinoma: rationale and clinical data
Maria Pipa-Muniz1, Maria Varela, Luisa Gonzalez-Dieguez,Manuel Rodguez
Therapeutic Prospective: Clinical Investigation
-
Personalized medicine in hepatocellular carcinoma: rationale and clinical data
Maria Pipa-Muniz1, Maria Varela, Luisa Gonzalez-Dieguez,Manuel Rodguez
Therapeutic Prospective: Clinical Investigation
-
The IMPROVE-IT trial: current status and potential clinical implications of ezetimibe
Finn Akerstrm, Luis Rodriguez-Padial
Review Article: Clinical Investigation
-
The IMPROVE-IT trial: current status and potential clinical implications of ezetimibe
Finn Akerstrm, Luis Rodriguez-Padial
Review Article: Clinical Investigation
-
The IMPROVE-IT trial: current status and potential clinical implications of ezetimibe
Finn Akerstrm, Luis Rodriguez-Padial
Review Article: Clinical Investigation
-
The IMPROVE-IT trial: current status and potential clinical implications of ezetimibe
Finn Akerstrm, Luis Rodriguez-Padial
Review Article: Clinical Investigation
-
The IMPROVE-IT trial: current status and potential clinical implications of ezetimibe
Finn Akerstrm, Luis Rodriguez-Padial
Review Article: Clinical Investigation
-
The IMPROVE-IT trial: current status and potential clinical implications of ezetimibe
Finn Akerstrm, Luis Rodriguez-Padial
Review Article: Clinical Investigation
-
The IMPROVE-IT trial: current status and potential clinical implications of ezetimibe
Finn Akerstrm, Luis Rodriguez-Padial
Review Article: Clinical Investigation
-
The IMPROVE-IT trial: current status and potential clinical implications of ezetimibe
Finn Akerstrm, Luis Rodriguez-Padial
Review Article: Clinical Investigation